Provided by Tiger Fintech (Singapore) Pte. Ltd.

INTELLIGENT BIO SOLUTIONS INC

1.36
+0.01000.74%
Post-market: 1.400.0394+2.90%18:06 EDT
Volume:38.15K
Turnover:52.13K
Market Cap:9.22M
PE:-0.43
High:1.42
Open:1.36
Low:1.33
Close:1.35
Loading ...

BRIEF-Intelligent Bio Solutions Files For Mixed Shelf Of Up To $100 Million - SEC Filing

Reuters
·
12 Apr

Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System

GlobeNewswire
·
31 Mar

Intelligent Bio Solutions to highlight drug testing tech at 2025 NDASA

TIPRANKS
·
28 Mar

Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show

GlobeNewswire
·
28 Mar

BRIEF-Intelligent Bio Solutions Highlights Continued Expansion With Strategic Partnership In Spain And Andorra

Reuters
·
27 Mar

Intelligent Bio Solutions Highlights Continued Expansion With Strategic Partnership in Spain and Andorra

THOMSON REUTERS
·
27 Mar

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

GlobeNewswire
·
27 Mar

BRIEF-Intelligent Bio Solutions Granted U.S. Patent For Fingerprinting Drug Screening Cartridge

Reuters
·
26 Mar

Intelligent Bio Solutions Inc - Granted U.S. Patent for Fingerprinting Drug Screening Cartridge

THOMSON REUTERS
·
26 Mar

Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry

GlobeNewswire
·
26 Mar

Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch

THOMSON REUTERS
·
25 Mar

EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch

Benzinga
·
25 Mar

Intelligent Bio Solutions Expecting to Get US Patent to Enhance Protection of Lateral Flow Technology

MT Newswires Live
·
20 Mar

Intelligent Bio Solutions to Expand U.S. Ip Portfolio With Expected Patent Grant

THOMSON REUTERS
·
20 Mar

Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant

GlobeNewswire
·
20 Mar

Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th

GlobeNewswire
·
11 Mar

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock

GlobeNewswire
·
22 Feb

BRIEF-Intelligent Bio Solutions Announces Proposed Public Offering Of Common Stock

Reuters
·
20 Feb

Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
20 Feb

Intelligent Bio Solutions Second Quarter 2025 Earnings: US$0.50 loss per share (vs US$2.07 loss in 2Q 2024)

Simply Wall St.
·
15 Feb